Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis
Abstract Background Small studies have implicated plasminogen activator inhibitor-1 (PAI-1) as a predictor of cardiovascular events; however, these findings have been inconsistent. We sought out to examine the potential role of PAI-1 as a marker for major adverse cardiovascular events (MACE). Method...
Main Authors: | Richard G. Jung, Pouya Motazedian, F. Daniel Ramirez, Trevor Simard, Pietro Di Santo, Sarah Visintini, Mohammad Ali Faraz, Alisha Labinaz, Young Jung, Benjamin Hibbert |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12959-018-0166-4 |
Similar Items
-
Does intravenous administration of recombinant tissue plasminogen activator for ischemic stroke can cause inferior myocardial infarction?
by: Mostafa Almasi, et al.
Published: (2016-06-01) -
Plasminogen Receptors and Fibrinolysis
by: Lindsey A. Miles, et al.
Published: (2021-02-01) -
Plasminogen interaction with Trypanosoma cruzi
by: Laura Almeida, et al.
Published: (2004-02-01) -
Study of the sites of plasminogen molecule which are responsible for inhibitory effect of Lys-plasminogen on platelet aggregation
by: Y. M. Roka-Moya, et al.
Published: (2014-10-01) -
Cardiovascular Events Among Survivors of Sepsis Hospitalization: A Retrospective Cohort Analysis
by: Jacob C. Jentzer, et al.
Published: (2023-02-01)